Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Chronic Disease Risk and Intervention Strategies - LOI

University of Alberta

$10,000.00

Long-term cardiovascular and respiratory outcomes of extreme prematurity: halting the developmental origins of adult diseases.

FY 2010-11

Summary
Our goal is to understand how the lungs and heart of babies born too early (extreme premature infants) function later in life. This is important because 10% of children are born prematurely. More and more premature babies are now surviving, even those born as early as 16 weeks before the due date (24 weeks of pregnancy instead of 40 weeks). One of the main risks of being born early is a chronic lung disease called bronchopulmonary dysplasia (BPD). BPD results from breathing machine and oxygen treatment for inability to breathe in babies born too early. Breathing machines and oxygen help these babies survive, but at the same time damage their still growing lungs. Today, we still do not know enough about how premature birth affects lung and heart growth. It may cause shortness of breath, wheezing, and early aging of the lung and heart. For example, these babies may have early-onset emphysema, usually seen in smokers and adults with chronic obstructive pulmonary disease, (COPD), pulmonary hypertension (high blood pressure in the lungs) or systemic hypertension because the blood vessels in the lung did not grow. The early stages of these diseases may not cause symptoms at rest. If detected early, we will be able to do something about it. First, we will look at models of newborn lung injury in the lab to see whether they develop abnormal lungs and hearts with aging and how this happens. Then we will compare in normal babies born at term and babies born preterm that have now reached school age or young adulthood and if those born premature have worse lung or heart function. Finally, we will test a new treatment in the lab that could prevent or repair the damaged lung. This treatment uses stem cells from the human cord blood. These cells seem to be able to repair the lung and protect other organs. The lab studies that we propose here will provide ultimate proof of the efficacy and safety of stem cells and pave the way for this type of treatment into the clinic.
Program
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
230204
Name
Thebaud Bernard
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Projecttitle
Long-term cardiovascular and respiratory outcomes of extreme prematurity: halting the developmental origins of adult diseases.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Team Grant: Chronic Disease Risk and Intervention Strategies - LOI
Keyworddelim
Aging; Angiogenesis; Chronic Lung Disease; Hypertension; Immunology; Inflammation; Oxidative Stress; Pulmonary Hypertension; Stem Cells
Abstract
Our goal is to understand how the lungs and heart of babies born too early (extreme premature infants) function later in life. This is important because 10% of children are born prematurely. More and more premature babies are now surviving, even those born as early as 16 weeks before the due date (24 weeks of pregnancy instead of 40 weeks). One of the main risks of being born early is a chronic lung disease called bronchopulmonary dysplasia (BPD). BPD results from breathing machine and oxygen treatment for inability to breathe in babies born too early. Breathing machines and oxygen help these babies survive, but at the same time damage their still growing lungs. Today, we still do not know enough about how premature birth affects lung and heart growth. It may cause shortness of breath, wheezing, and early aging of the lung and heart. For example, these babies may have early-onset emphysema, usually seen in smokers and adults with chronic obstructive pulmonary disease, (COPD), pulmonary hypertension (high blood pressure in the lungs) or systemic hypertension because the blood vessels in the lung did not grow. The early stages of these diseases may not cause symptoms at rest. If detected early, we will be able to do something about it. First, we will look at models of newborn lung injury in the lab to see whether they develop abnormal lungs and hearts with aging and how this happens. Then we will compare in normal babies born at term and babies born preterm that have now reached school age or young adulthood and if those born premature have worse lung or heart function. Finally, we will test a new treatment in the lab that could prevent or repair the damaged lung. This treatment uses stem cells from the human cord blood. These cells seem to be able to repair the lung and protect other organs. The lab studies that we propose here will provide ultimate proof of the efficacy and safety of stem cells and pave the way for this type of treatment into the clinic.
Competitiondate
201103
Approvedterm2
1 yr 0 mth
Pinamesdelim
Thebaud, Bernard; Lacaze-Masmonteil, Thierry; Lavoie, Pascal; Nuyt, Anne Monique
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~
University of Alberta - $10,000 Grant (2010-11) | Canada Spends